Clinical Features and Prognosis of Multiple Myeloma Patients with Secondary Primary Malignancies / 中国实验血液学杂志

OBJECTIVE@#To explore the clinical characteristics and prognosis of multiple myeloma(MM) patients with secondary primary malignancies.@*METHODS@#The clinical data of newly diagnosed MM patients admitted to the First Affiliated Hospital of Zhengzhou University from January 2011 to December 2019 were retrospectively analyzed. The patients with secondary primary malignancies were retrieved, and their clinical features and prognosis were evaluated.@*RESULTS@#A total of 1 935 patients with newly diagnosed MM were admitted in this period, with a median age of 62 (18-94) years old, of which 1 049 cases were hospitalized twice or more. There were eleven cases with secondary primary malignancies (the incidence rate was 1.05%), including three cases of hematological malignancies (2 cases of acute myelomonocytic leukemia and 1 case of acute promyelocytic leukemia) and eight cases of solid tumors (2 cases of lung adenocarcinoma, and 1 case each of endometrial cancer, esophageal squamous cell carcinoma, primary liver cancer, bladder cancer, cervical squamous cell carcinoma, and meningioma). The median age of onset was 57 years old. The median time between diagnosis of secondary primary malignancies and diagnosis of MM was 39.4 months. There were seven cases with primary or secondary plasma cell leukemia, the incidence rate was 0.67%, and the median age of onset was 52 years old. Compared with the randomized control group, the β2-microglobulin level in the secondary primary malignancies group was lower (P=0.028), and more patients were in stage I/II of ISS (P=0.029). Among the 11 patients with secondary primary malignancies, one survived, ten died, and the median survival time was 40 months. The median survival time of MM patients after the secondary primary malignancies was only seven months. All seven patients with primary or secondary plasma cell leukemia died, with a median survival time of 14 months. The median overall survival time of MM patients with secondary primary malignancies was longer than that of the patients with plasma cell leukemia (P=0.027).@*CONCLUSION@#The incidence rate of MM with secondary primary malignancies is 1.05%. MM patients with secondary primary malignancies have poor prognosis and short median survival time, but the median survival time is longer than that of patients with plasma cell leukemia.

Second Primary Cancer after Treating Gastrointestinal Cancer / 대한소화기학회지

Advances in diagnosis and therapeutic technologies have brought increased life expectancy for most cancers, but paradoxically it also has increased the risk of second primary malignancies. Cancer survivors have a higher risk of developing cancer than the general population. This suggests that more studies are needed to develop screen and management programs for cancer survivors, especially patients with gastrointestinal cancers, which are the most common cancers in Korea.

Second Primary Cancer after Treating Gastrointestinal Cancer / 대한소화기학회지

Advances in diagnosis and therapeutic technologies have brought increased life expectancy for most cancers, but paradoxically it also has increased the risk of second primary malignancies. Cancer survivors have a higher risk of developing cancer than the general population. This suggests that more studies are needed to develop screen and management programs for cancer survivors, especially patients with gastrointestinal cancers, which are the most common cancers in Korea.

Is radioactive iodine- 131 treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?

Objective Much controversy relates to the risk of non-synchronous second primary malignancies (NSSPM) after radioactive iodine treatment (RAI-131) in differentiated thyroid cancer (DTC) patients. This study evaluated the relationship between RAI-131 and NSSPM in DTC survivors with long-term follow-up. Materials and methods Retrospective analysis of 413 DTC cases was performed; 252 received RAI-131 and 161 were treated with thyroidectomy alone. Exclusion criteria were: prior or synchronous non-thyroidal malignancies (within the first year), familial syndromes associated to multiple neoplasms, ionizing radiation exposure or second tumors with unknown histopathology. Results During a mean follow-up of 11.0 ± 7.5 years, 17 (4.1%) patients developed solid NSSPM. Patients with NSSPM were older than those without (p = 0.02). RAI-131 and I-131 cumulative activity were similar in patients with and without NSSPM (p = 0.18 and p = 0.78, respectively). Incidence of NSSPM was 5.2% in patients with RAI-131 treatment and 2.5% in those without RAI-131 (p = 0.18). Using multivariate analysis, RAI-131 was not significantly associated with NSSPM occurrence (p = 0.35); age was the only independent predictor (p = 0.04). Under log rank statistical analysis, after 10 years of follow-up, it was observed a tendency of lower NSSPM-free survival among patients that received RAI-131 treatment (0.96 vs . 0.87; p = 0.06), what was not affected by age at DTC diagnosis. Conclusion In our cohort of DTC survivors, with a long-term follow-up period, RAI-131 treatment and I-131 cumulative dose were not significantly associated with NSSPM occurrence. A tendency of premature NSSPM occurrence among patients treated with RAI-131 was observed, suggesting an anticipating oncogenic effect by interaction with other risk factors.

A Case of Secondary Primary Malignancy after Lenalidomide Therapy for Multiple Myeloma / 대한내과학회지

Lenalidomide, an orally administered immune-modulating drug, has several mechanisms of action against multiple myeloma (MM). However, the mechanisms of action of immune-modulating drugs are not understood completely. Lenalidomide maintenance therapy prolongs the time to progression and increases the overall survival in patients with MM. However, secondary primary malignancy (SPM) has been noted as a serious adverse event in patients with MM treated with lenalidomide. Lenalidomide treatment is not covered by insurance. Consequently, physicians have little experience with the adverse events of lenalidomide treatment in patients with MM. Here, we describe a case of breast cancer after lenalidomide treatment for MM. To our knowledge, this is the first report of a lenalidomide-associated SPM in Korea. The risk factors associated with lenalidomide-associated SPM should be considered carefully when implementing chemotherapy regimens in patients with MM.

Morfología de la Piel y Producción de Lana en Cruzamiento Absorbente con Merino Multipropósito / Skin Morphology and Wool Production on Merino Multipurpose from Absorbent Crosses

Las tendencias del mercado de fibras textiles muestran que las lanas finas son las que se adaptan a las preferencias de la industria textil. En Argentina, la producción de lanas finas es insignificante y esto representa una limitante para el crecimiento lanero del país. La necesidad de desarrollar una alternativa de producción ovina lleva a considerar al Merino Multipropósito como una opción interesante. En la provincia de Corrientes, se iniciaron cruzamientos con estos animales, pero existen inquietudes con respecto a lograr una disminución en el diámetro de la fibra y que repercuta en el peso del vellón. El objetivo del trabajo fue evaluar el efecto del cruzamiento de ovejas Corriedale con machos MPM, sobre las características de la piel y la producción y calidad de lana. Los parámetros evaluados fueron diámetro de fibra, densidad de folículos y relación S/P. Para el recuento de folículos primarios y secundarios se realizaron biopsias de piel con auxilio de un sacabocado. Las características en relación con la producción y calidad de lana se consideraron entre borregas contemporáneas. La comparación realizada en este trabajo permitiría atribuir la disminución del diámetro de fibra, al cruzamiento con MPM. La densidad de folículos en las madres Corriedale, en las borregas Corriedale y en la F1 (Corriedale x MPM) fueron diferente significativamente. La relación S/P fue 9,08 ± 2,32, 9,46 ± 1,57, y 11,93± 2,18, respectivamente. El peso del vellón en borregas de la F1 (Corriedale x MPM) fue inferior y significativamente diferente de sus contemporáneas Corriedale. El rinde al lavado en las borregas Corriedale fue superior al de las borregas nacidas del cruzamiento con MPM. Las diferencias fueron significativas en el largo de mecha entre borregas Corriedale y Corriedale x MPM. En las condiciones realizadas no se pudo comprobar todas las expectativas esperadas con el cruzamiento. Nuevas experiencias serán necesarias para respaldar morfológica y productivamente la posible inversión.

Textile market trends show that fine wools are more suitable to reach the preferences of textile industry. Production of fine wool in Argentina are insignificant, which is a limitation on the development of the country. The need to develop new alternatives of production leads us consider the Multipurpose Merinos as an option. Crossbreeding with these animals began at Corrientes state in order to achieve a reduction in the diameter of fiber and an impact on the weight of the fleece. These crossbreedings with Corriedale sheep were carried out with the objective of analyzing changes on wool production, quality and skin characteristics. Evaluation parameters were fiber diameter, density of follicles and Secondary/Primary relation. Follicle count primary and secondary were made from skin biopsies and were performed with the aid of a punch. Features regarding the production and quality of wool from sheep were considered in contemporary animals, evaluating fleece weight and clean dirty, length of strands, washing yields, coefficient variation of fiber and W / D3. The comparison made in this paper would attribute the decrease in fiber diameter to the crossing with MPM. The follicle density on Corriedale ewes, Corriedale ewe lambs in and the F1 (Corriedale x MPM) were significantly different. The S / P was 9,08 ± 2,32 ; 9.46 ± 1.57 and 11,93 ± 2,18 respectively. The fleece weight in the F1 ewe lambs (Corriedale x MPM) was lower and significantly different from its Corriedale contemporaries. The yield on wash fleece at Corriedale ewe lambs was higher than ewe lambs crossbred with MPM. The differences were significant in length of strands between Corriedale and Corriedale sheep x MPM. Expected results from the crossbreeding could not be substantiated under the conditions realized. Additional studies will be needed to support possible morphological and productive investment.